CRISPR, Doudna, Aduro, Amgen, NEA & More
Summary
First, because she and her colleagues are in a rip-roaring patent fight over the ownership of CRISPR/Cas9—see our item below—and second, because Time Magazine named Doudna and her co-inventor, the European-based Emmanuelle Charpentier, to its list of the year’s 100 most influential people.A trove of documents supporting their case, including a declaration from gene editing pioneer Dana Carroll, were published on the PTO website Monday.—San Francisco-based women’s health firm Medicines360, which has built a unique nonprofit business model, has launched a new intrauterine device (IUD) for contraception, branded Liletta.—San Francisco-based Benchling, a maker of cloud-based tools for life science data sharing and analysis, said Wednesday it has raised a $5 million Series A round led by Andreessen Horowitz.—Researchers at the University of Washington in Seattle are teaming up with Medtronic to develop a deep brain stimulation device to treat people with essential tremor, a chronic shaking of the hands.
Classifications
AskAI Classifications
LabelsLinked Companies
